表紙
市場調查報告書

歐洲的新冠狀病毒檢測套組市場:2020年∼2024年

Coronavirus Test Kits Market in Europe 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 932423
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
歐洲的新冠狀病毒檢測套組市場:2020年∼2024年 Coronavirus Test Kits Market in Europe 2020-2024
出版日期: 2020年04月15日內容資訊: 英文 120 Pages
簡介

歐洲的新冠狀病毒檢測套組市場在2020年∼2024年的預測期間內,預計將以32%的年複合成長率增長,達到1億3,905萬美元的規模。市場成長的主要因素有政府的財政補助增加和策略性聯盟的增加。特別是政府財政補助的增加有望進一步促進市場增長。

本報告提供歐洲的新冠狀病毒檢測套組市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年到2024年的預測

波特的五力分析

各終端用戶市場區隔

  • 市場區隔
  • 各終端用戶比較:市場規模·預測(2019年∼2024年)
  • 政府
  • 非政府
  • 各終端用戶市場機會

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模·預測(2019年∼2024年)
  • 德國
  • 義大利
  • 英國
  • 法國
  • 其他歐洲
  • 主要國家
  • 各地區的市場機會

成長要素,課題,趨勢

  • 市場成長要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • 3D Biomedicine Science and Technology Co. Ltd.
  • Abbott Laboratories
  • BGI Genomics Co. Ltd.
  • bioMerieux SA
  • Co-Diagnostics Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

附錄

目錄
Product Code: IRTNTR43247

Technavio has been monitoring the coronavirus test kits market in Europe and it is poised to grow by $ -139.05 mn during 2020-2024 progressing at a CAGR of 32% during the forecast period. Our reports on coronavirus test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current Europe market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing government funding and growing number of strategic alliances. In addition, increasing government funding is anticipated to boost the growth of the market as well.

The coronavirus test kits market in Europe market analysis include end-user segment and geographic landscapes.

Technavio's ‘ coronavirus test kits market in Europe ’ is segmented as below:

By End-user

  • Government
  • Non-government

By Geographic Landscapes

  • Germany
  • Italy
  • UK
  • France
  • Rest of Europe

This study identifies the rising focus on prevention of coronavirus pandemic as one of the prime reasons driving the coronavirus test kits market in Europe growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our coronavirus test kits market in Europe covers the following areas:

  • Coronavirus test kits market in Europe sizing
  • Coronavirus test kits market in Europe forecast
  • Coronavirus test kits market in Europe industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., bioMA©rieux SA, Co-Diagnostics Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc.. Also, the coronavirus test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Government - Market size and forecast 2019-2024
  • Non-government - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Germany - Market size and forecast 2019-2024
  • Italy - Market size and forecast 2019-2024
  • UK - Market size and forecast 2019-2024
  • France - Market size and forecast 2019-2024
  • Rest of Europe - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • 3D Biomedicine Science and Technology Co. Ltd.
  • Abbott Laboratories
  • BGI Genomics Co. Ltd.
  • bioMerieux SA
  • Co-Diagnostics Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Parent market
  • 8.Market characteristics
  • 9.Offerings of vendors included in the market definition
  • 10.Market segments
  • 11.Global - Market size and forecast 2019 - 2024 ($ million)
  • 12.Global market: Year-over-year growth 2019 - 2024 (%)
  • 13.Five forces analysis 2019 & 2024
  • 14.Bargaining power of buyers
  • 15.Bargaining power of suppliers
  • 16.Threat of new entrants
  • 17.Threat of substitutes
  • 18.Threat of rivalry
  • 19.Market condition - Five forces 2019
  • 20.End user - Market share 2019-2024 (%)
  • 21.Comparison by End user
  • 22.Government - Market size and forecast 2019-2024 ($ million)
  • 23.Government - Year-over-year growth 2019-2024 (%)
  • 24.Non-government - Market size and forecast 2019-2024 ($ million)
  • 25.Non-government - Year-over-year growth 2019-2024 (%)
  • 26. Market opportunity by End user
  • 27.Customer landscape
  • 28.Market share by geography 2019-2024 (%)
  • 29.Geographic comparison
  • 30.Germany - Market size and forecast 2019-2024 ($ million)
  • 31.Germany - Year-over-year growth 2019-2024 (%)
  • 32.Italy - Market size and forecast 2019-2024 ($ million)
  • 33.Italy - Year-over-year growth 2019-2024 (%)
  • 34.UK - Market size and forecast 2019-2024 ($ million)
  • 35.UK - Year-over-year growth 2019-2024 (%)
  • 36.France - Market size and forecast 2019-2024 ($ million)
  • 37.France - Year-over-year growth 2019-2024 (%)
  • 38.Rest of Europe - Market size and forecast 2019-2024 ($ million)
  • 39.Rest of Europe - Year-over-year growth 2019-2024 (%)
  • 40.Key leading countries
  • 41.Market opportunity by geography ($ million)
  • 42.Impact of drivers and challenges
  • 43.Vendor landscape
  • 44.Landscape disruption
  • 45.Industry risks
  • 46.Vendors covered
  • 47.Market positioning of vendors
  • 48.3D Biomedicine Science and Technology Co. Ltd. - Overview
  • 49.3D Biomedicine Science and Technology Co. Ltd. - Business segments
  • 50.3D Biomedicine Science and Technology Co. Ltd. - Key offerings
  • 51.3D Biomedicine Science and Technology Co. Ltd. - Key customers
  • 52.3D Biomedicine Science and Technology Co. Ltd. - Segment focus
  • 53.Abbott Laboratories - Overview
  • 54.Abbott Laboratories - Business segments
  • 55.Abbott Laboratories - Key offerings
  • 56.Abbott Laboratories - Key customers
  • 57.Abbott Laboratories - Segment focus
  • 58.BGI Genomics Co. Ltd. - Overview
  • 59.BGI Genomics Co. Ltd. - Product and service
  • 60.BGI Genomics Co. Ltd. - Key offerings
  • 61.BGI Genomics Co. Ltd. - Key customers
  • 62.BGI Genomics Co. Ltd. - Segment focus
  • 63.bioMerieux SA - Overview
  • 64.bioMerieux SA - Business segments
  • 65.bioMerieux SA - Key offerings
  • 66.bioMerieux SA - Key customers
  • 67.bioMerieux SA - Segment focus
  • 68.Co-Diagnostics Inc. - Overview
  • 69.Co-Diagnostics Inc. - Product and service
  • 70.Co-Diagnostics Inc. - Key offerings
  • 71.Co-Diagnostics Inc. - Key customers
  • 72.Co-Diagnostics Inc. - Segment focus
  • 73.Danaher Corp. - Overview
  • 74.Danaher Corp. - Business segments
  • 75.Danaher Corp. - Key offerings
  • 76.Danaher Corp. - Key customers
  • 77.Danaher Corp. - Segment focus
  • 78.F. Hoffmann-La Roche Ltd. - Overview
  • 79.F. Hoffmann-La Roche Ltd. - Business segments
  • 80.F. Hoffmann-La Roche Ltd. - Key offerings
  • 81.F. Hoffmann-La Roche Ltd. - Key customers
  • 82.F. Hoffmann-La Roche Ltd. - Segment focus
  • 83.Guangzhou Wondfo Biotech Co. Ltd. - Overview
  • 84.Guangzhou Wondfo Biotech Co. Ltd. - Business segments
  • 85.Guangzhou Wondfo Biotech Co. Ltd. - Key offerings
  • 86.Guangzhou Wondfo Biotech Co. Ltd. - Key customers
  • 87.Guangzhou Wondfo Biotech Co. Ltd. - Segment focus
  • 88.QIAGEN NV - Overview
  • 89.QIAGEN NV - Business segments
  • 90.QIAGEN NV - Key offerings
  • 91.QIAGEN NV - Key customers
  • 92.QIAGEN NV - Segment focus
  • 93.Thermo Fisher Scientific Inc. - Overview
  • 94.Thermo Fisher Scientific Inc. - Business segments
  • 95.Thermo Fisher Scientific Inc. - Key offerings
  • 96.Thermo Fisher Scientific Inc. - Key customers
  • 97.Thermo Fisher Scientific Inc. - Segment focus
  • 98.Currency conversion rates for US$
  • 99.Research Methodology
  • 100.Validation techniques employed for market sizing
  • 101.Information sources
  • 102.List of abbreviations